---
title: "Phenacemide - Epilepsy"
sidebar: mydoc_sidebar
permalink: db01121-mesh-d004827-1.html
toc: false 
---


Path ID: `DB01121_MESH_D004827_1`
{% include image.html url="images/db01121-mesh-d004827-1.png" file="db01121-mesh-d004827-1.png" alt="db01121-mesh-d004827-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C005396 | Phenacemide | Drug |
| UniProt:P35498 | Sodium channel protein type 1 subunit alpha | Protein |
| GO:0019228 | Neuronal action potential | BiologicalProcess |
| HP:0001250 | Seizure | PhenotypicFeature |
| MESH:D004827 | Epilepsy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Phenacemide | DECREASES ACTIVITY OF | Sodium Channel Protein Type 1 Subunit Alpha |
| Sodium Channel Protein Type 1 Subunit Alpha | POSITIVELY REGULATES | Neuronal Action Potential |
| Neuronal Action Potential | POSITIVELY CORRELATED WITH | Seizure |
| Seizure | MANIFESTATION OF | Epilepsy |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB01121#mechanism-of-action](https://go.drugbank.com/drugs/DB01121#mechanism-of-action){:target="_blank"}